Document is current
Any future updates will be listed below
-
Authors
Sparling, A. Clare https://orcid.org/0009-0001-1807-0221
Ward, James M. https://orcid.org/0000-0002-9510-2848
Sarkar, Kakali
Schiffenbauer, Adam
Farhadi, Payam Noroozi https://orcid.org/0000-0003-2419-050X
Smith, Michael A.
Rahman, Saifur
Zerrouki, Kamelia
Miller, Frederick W. https://orcid.org/0000-0003-2831-9593
Li, Jian-Liang
Casey, Kerry A.
Rider, Lisa G. https://orcid.org/0000-0002-6912-2458
-
Funding
Funding for this research was provided by:
National Institute of Environmental Health Sciences
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 21 October 2024
First Online: 11 November 2024
Declarations
:
: All patient data came from an institutional review board-approved studies at National Institutes of Health (NIH) (NCT00059748) and at MedImmune. Informed consent was obtained from all study participants.
: Not applicable.
: K.C., M.S., and S.R. are former employees and shareholders of AstraZeneca. A.S. is a shareholder of AstraZeneca stock, and his spouse is employed by AstraZenca. A.C.S., F.M., J.L., J.W., K.C., K.S., K.Z., L.R., M.S., P.N.F., and S.R. declare no conflicts of interest.
